+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Genentech, Inc.  - logo

Genentech, Inc., a biotechnology company, engages in the research, development, manufacture, and marketing of biotechnology products for treating patients with serious or life-threatening diseases in the United States. It offers molecular entities and medicines in the areas of oncology, immunology, neuroscience, metabolism, and infectious diseases. The company was founded in 1976 and is headquartered in South San Francisco, California. Genentech operates as a subsidiary of Roche Holdings, Inc.

Rare Hemophilia Factors Market 2024-2028 - Product Thumbnail Image

Rare Hemophilia Factors Market 2024-2028

  • Report
  • July 2024
  • 142 Pages
  • Global
From
From
From
From
Companion Diagnostics (CDx) Market Report 2024-2034 - Product Thumbnail Image

Companion Diagnostics (CDx) Market Report 2024-2034

  • Report
  • January 2024
  • 307 Pages
  • Global
From
Bispecific Antibodies - Global Strategic Business Report - Product Thumbnail Image

Bispecific Antibodies - Global Strategic Business Report

  • Report
  • October 2025
  • 104 Pages
  • Global
From
From
Fanconi Anemia Treatment Market - Global Forecast to 2030 - Product Thumbnail Image

Fanconi Anemia Treatment Market - Global Forecast to 2030

  • Report
  • August 2025
  • 187 Pages
  • Global
From
From
From
Cell Therapy Clinical Activity and Process Automation - Product Thumbnail Image

Cell Therapy Clinical Activity and Process Automation

  • Report
  • July 2023
  • 100 Pages
  • Global
From
From
Metastatic Breast Cancer Treatment Market Report 2025 - Product Thumbnail Image

Metastatic Breast Cancer Treatment Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Loading Indicator